Research analysts at Leerink Swann boosted their FY2015 earnings per share estimates for Carbylan Therapeutics (NASDAQ:CBYL) in a research note issued to investors on Wednesday, Zacks reports. Leerink Swann analyst J. Gerberry now forecasts that the firm will post earnings per share of ($1.27) for the year, up from their previous estimate of ($1.32). Leerink […]
